The ACAAI and AAAAI have worked together to develop a suggested approach to coding for oral immunotherapy (OIT) for peanut desensitization using an FDA-approved product. Read the guidance here.

You should check with the relevant health plan or payer on coverage, coding and reimbursement, and get documentation in writing whenever possible. We hope that, in addition to that due diligence, this guidance is useful for your practice.